Sai Parenterals’ subsidiary to acquire majority stake in Bion Therapeutics before November 2026 Back
<p>Sai Parenterals Limited announced that its board approved an agreement for its wholly owned subsidiary, SP Analytics Private Limited, to acquire a majority stake in Hyderabad-based branded formulations prescription business company, Bion Therapeutics India Private Limited, in an all-cash deal expected to be completed before November 30, 2026. The acquisition will make Bion a step-down subsidiary of Sai Parenterals, with Bion reporting a turnover of Rs 28.22 crore for the half-year ended September 30, 2026, and Sai Parenterals will provide funding support to SP Analytics for the acquisition utilizing proceeds from its IPO and debt.</p>